EGFR c.880A>G ;(p.K294E)

Variant ID: 7-55221836-A-G

NM_005228.3(EGFR):c.880A>G;(p.K294E)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


The effects of combination treatments on drug resistance in chronic myeloid leukaemia: an evaluation of the tyrosine kinase inhibitors axitinib and asciminib.

Bmc Cancer
G Lindström, H Jonathan HJ; Friedman, Ran R
Publication Date: 2020-05-07

Variant appearance in text: EGFR: K294E
PubMed Link: 32380976
Variant Present in the following documents:
  • Main text
  • 12885_2020_Article_6782.pdf
View BVdb publication page



ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.

Oncotarget
Geißler, Anna-Lena AL; Geißler, Miriam M; Kottmann, Daniel D; Lutz, Lisa L; Fichter, Christiane D CD; Fritsch, Ralph R; Weddeling, Britta B; Makowiec, Frank F; Werner, Martin M; Lassmann, Silke S
Publication Date: 2017-03-07

Variant appearance in text: EGFR: Lys294Glu
PubMed Link: 28199979
Variant Present in the following documents:
  • oncotarget-08-17164-s001.pdf
View BVdb publication page